MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MXCT MaxCyte Inc

休市中 05-31 16:00:00 EDT

4.48

-0.17

-3.66%

盘后4.47

-0.01-0.22%

17:59 EDT

最高4.73	最低4.38	成交量32.53万
今开4.65	昨收4.65	日振幅7.42%
总市值4.68亿	流通市值4.06亿	总股本1.05亿
成交额146.78万	换手率0.36%	流通股本9,058万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MXCT","market":"US","secType":"STK","nameCN":"MaxCyte Inc","latestPrice":4.48,"timestamp":1717185600000,"preClose":4.65,"halted":0,"volume":325257,"hourTrading":{"tag":"盘后","latestPrice":4.47,"preClose":4.48,"latestTime":"17:59 EDT","volume":51377,"amount":230167.2528,"timestamp":1717192787738},"delay":0,"floatShares":90584678,"shares":104544289,"eps":-0.353033,"marketStatus":"休市中","marketStatusCode":7,"change":-0.17,"latestTime":"05-31 16:00:00 EDT","open":4.65,"high":4.725,"low":4.38,"amount":1467842.55759,"amplitude":0.074194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.353033,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"listingDate":1627617600000,"adjPreClose":4.65,"postHourTrading":{"tag":"盘后","latestPrice":4.47,"preClose":4.48,"latestTime":"17:59 EDT","volume":51377,"amount":230167.2528,"timestamp":1717192787738},"volumeRatio":1.1146645466385647},"requestUrl":"/m/hq/s/MXCT/tweets","defaultTab":"tweets","newsList":[{"id":"2439307923","title":"Maxcyte, Inc.盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439307923","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2439307923?lang=zh_cn&edition=full","pubTime":"2024-05-29 00:26","pubTimestamp":1716913581,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日00时26分，Maxcyte, Inc.股票出现波动，股价快速上涨5.07%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.14%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052900262296810481&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052900262296810481&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2437626802","title":"MaxCyte 与 Legend Biotech 签署战略平台许可协议加速细胞疗法的发现和开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2437626802","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2437626802?lang=zh_cn&edition=full","pubTime":"2024-05-22 20:15","pubTimestamp":1716380159,"startTime":"0","endTime":"0","summary":"MaxCyte 与 Legend Biotech 签署战略平台许可协议加速细胞疗法的发现和开发","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405222016009ed99d47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405222016009ed99d47&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435356280","title":"Maxcyte, Inc.2024财年第一财季实现净利润-9.53百万美元，同比增加12.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435356280","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435356280?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:17","pubTimestamp":1715530639,"startTime":"0","endTime":"0","summary":"3月31日，Maxcyte, Inc.公布财报，公告显示公司2024财年第一财季净利润为-9.53百万美元，同比增加12.41%；其中营业收入为11.34百万美元，同比增加32.17%，每股基本收益为-0.09美元。从资产负债表来看，Maxcyte, Inc.总负债31.57百万美元，其中短期债务825000.00美元，资产负债比为0.09，流动比率为0.14。机构评级：截至2024年3月31日，当前有6家机构对Maxcyte, Inc.目标价做出预测，其中目标均价为8.45美元，其中最低目标价为4.12美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130017258afe9084&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130017258afe9084&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433729228","title":"Maxcyte, Inc.盘中异动 股价大涨5.85%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729228","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433729228?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:31","pubTimestamp":1715175110,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时31分，Maxcyte, Inc.股票出现波动，股价急速拉升5.85%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.65%。其相关个股中，Tivic Health Systems, Inc.、Globus Medical, Inc.、Inogen, Inc涨幅较大，Tivic Health Systems, Inc.、Helius Medical Technologies, Inc.、Nuwellis, Inc.较为活跃，换手率分别为482.14%、85.35%、10.96%，振幅较大的相关个股有Tivic Health Systems, Inc.、Nuwellis, Inc.、Inogen, Inc，振幅分别为28.57%、11.92%、11.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082131507a58c338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082131507a58c338&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420793532","title":"Maxcyte, Inc.盘中异动 早盘快速拉升5.04%报4.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420793532","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420793532?lang=zh_cn&edition=full","pubTime":"2024-03-19 23:12","pubTimestamp":1710861123,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日23时12分，Maxcyte, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报4.38美元/股，成交量14.8717万股，换手率0.14%，振幅7.32%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319231203791b7c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319231203791b7c3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419682184","title":"Maxcyte, Inc.盘中异动 早盘快速上涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419682184","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419682184?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:35","pubTimestamp":1710336956,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时35分，Maxcyte, Inc.股票出现异动，股价急速上涨5.28%。Maxcyte, Inc.股票所在的医疗器械行业中，整体涨幅为0.24%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313213557791a1a68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313213557791a1a68&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419576275","title":"Maxcyte, Inc.2023财年实现净利润-37.92百万美元，同比减少60.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419576275","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419576275?lang=zh_cn&edition=full","pubTime":"2024-03-13 15:20","pubTimestamp":1710314422,"startTime":"0","endTime":"0","summary":"12月31日，Maxcyte, Inc.公布财报，公告显示公司2023财年净利润为-37.92百万美元，同比减少60.88%；其中营业收入为41.29百万美元，同比减少6.71%，每股基本收益为-0.37美元。从资产负债表来看，Maxcyte, Inc.总负债36.11百万美元，其中短期债务774000.00美元，资产负债比为0.08，流动比率为0.11。机构评级：截至2023年12月31日，当前有5家机构对Maxcyte, Inc.目标价做出预测，其中目标均价为9.75美元，其中最低目标价为7.00美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313154055877b4f3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313154055877b4f3a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417412066","title":"Maxcyte, Inc.盘中异动 股价大跌5.14%报4.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417412066","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417412066?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:56","pubTimestamp":1709650607,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时56分，Maxcyte, Inc.股票出现波动，股价大幅下挫5.14%。截至发稿，该股报4.43美元/股，成交量10.0313万股，换手率0.10%，振幅3.75%。Maxcyte, Inc.股票所在的医疗器械行业中，整体跌幅为0.17%。Maxcyte, Inc.公司简介：MaxCyte Inc 是一家商业细胞工程公司，专注于提供支持平台技术，以推进下一代细胞疗法的发现、开发和商业化，并支持基于细胞的研究和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305225648861db6d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305225648861db6d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409374854","title":"Maxcyte Inc盘中异动 临近午盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409374854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409374854?lang=zh_cn&edition=full","pubTime":"2024-02-06 00:42","pubTimestamp":1707151363,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日00时42分，Maxcyte Inc股票出现波动，股价急速下跌5.05%。截至发稿，该股报4.89美元/股，成交量12.5717万股，换手率0.12%，振幅4.27%。Maxcyte Inc股票所在的医疗器械行业中，整体跌幅为0.34%。其相关个股中，Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Envoy Medical Inc涨幅较大，Intelligent Bio Solutions Inc、Sintx Technologies Inc、Motus Gi Holdings Inc较为活跃，换手率分别为205.28%、20.75%、7.00%，振幅较大的相关个股有Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Envoy Medical Inc，振幅分别为66.73%、59.67%、45.61%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060042437a418448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060042437a418448&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407360468","title":"Maxcyte Inc盘中异动 大幅下跌5.15%报4.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407360468","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407360468?lang=zh_cn&edition=full","pubTime":"2024-01-31 01:19","pubTimestamp":1706635148,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日01时19分，Maxcyte Inc股票出现异动，股价急速下挫5.15%。截至发稿，该股报4.89美元/股，成交量14.5725万股，换手率0.14%，振幅6.37%。Maxcyte Inc股票所在的医疗器械行业中，整体跌幅为0.40%。其相关个股中，Vivos Therapeutics Inc、Spectral Ai Inc、Bone Biologics Corp C/Wts 13/10/2026 涨幅较大，Motus Gi Holdings Inc、Vivos Therapeutics Inc、Spectral Ai Inc较为活跃，换手率分别为741.09%、47.31%、34.50%，振幅较大的相关个股有Spectral Ai Inc、Vivos Therapeutics Inc、Tivic Health Systems Inc，振幅分别为52.08%、44.48%、42.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013101190887e69e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013101190887e69e68&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405064841","title":"Maxcyte Inc盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405064841","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405064841?lang=zh_cn&edition=full","pubTime":"2024-01-24 03:02","pubTimestamp":1706036574,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日03时02分，Maxcyte Inc股票出现波动，股价大幅拉升5.03%。截至发稿，该股报5.22美元/股，成交量47.0589万股，换手率0.45%，振幅4.23%。Maxcyte Inc股票所在的医疗器械行业中，整体跌幅为0.80%。其相关个股中，Nuwellis Inc、Tenon Medical Inc C/Wts 16/06/2028 、Sensus Healthcare Inc涨幅较大，Glaukos Corporation、Vivos Therapeutics Inc、Nuwellis Inc较为活跃，换手率分别为12.49%、10.02%、9.67%，振幅较大的相关个股有Nuwellis Inc、Trisalus Life Sciences Inc C/Wts 10/08/28 、Catheter Precision Inc，振幅分别为47.36%、37.10%、24.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012403025487e67c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012403025487e67c00&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405880170","title":"BUZZ-MaxCyte 因与 Imugene 合作开发抗癌药物而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2405880170","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2405880170?lang=zh_cn&edition=full","pubTime":"2024-01-24 01:48","pubTimestamp":1706032122,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月23日 - ** 细胞工程公司MaxCyte   股价上涨4.2%至5.18美元 ** 该公司称 (link) 它签署了一项协议，允许 Imugene    使用 MaxCyte 的流式电穿孔技术和 ExPERT 平台开发其癌症药物** 称有权获得平台许可费和项目相关收入作为回报** 截至上次收盘，股价在过去 12 个月下跌了 9.3","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402139555","title":"Maxcyte Inc盘中异动 早盘急速上涨7.52%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402139555","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402139555?lang=zh_cn&edition=full","pubTime":"2024-01-09 22:31","pubTimestamp":1704810668,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日22时31分，Maxcyte Inc股票出现波动，股价快速拉升7.52%。截至发稿，该股报4.94美元/股，成交量3.0209万股，换手率0.03%，振幅2.40%。Maxcyte Inc股票所在的医疗器械行业中，整体跌幅为0.36%。其相关个股中，Clearpoint Neuro Inc、古特拉、Spectral Ai Inc C/Wts 09/11/2028 涨幅较大，Nuwellis Inc、古特拉、Motus Gi Holdings Inc较为活跃，换手率分别为2.93%、2.22%、1.79%，振幅较大的相关个股有Brainsway Ltd、Orthofix Medical Inc、Intelligent Bio Solutions Inc，振幅分别为7.31%、6.17%、5.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010922310881a9523c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010922310881a9523c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400935118","title":"Maxcyte Inc盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400935118","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400935118?lang=zh_cn&edition=full","pubTime":"2024-01-03 04:10","pubTimestamp":1704226235,"startTime":"0","endTime":"0","summary":"北京时间2024年01月03日04时10分，Maxcyte Inc股票出现异动，股价急速拉升5.11%。截至发稿，该股报4.94美元/股，成交量51.6974万股，换手率0.50%，振幅7.02%。Maxcyte Inc股票所在的医疗器械行业中，整体跌幅为1.02%。其相关个股中，Heart Test Laboratories Inc C/Wts 17/06/2027 、Envoy Medical Inc C/Wts 29/09/2028 、Pavmed Inc C/Wts 30/04/2024 Class Z涨幅较大，Nuwellis Inc、Bone Biologics Corp、Reshape Lifesciences Inc较为活跃，换手率分别为89.94%、10.49%、8.92%，振幅较大的相关个股有Tenon Medical Inc C/Wts 16/06/2028 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、Trisalus Life Sciences Inc C/Wts 10/08/28 ，振幅分别为84.75%、81.12%、31.93%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401030410357905a8b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401030410357905a8b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393111298","title":"Maxcyte Inc盘中异动 临近收盘大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393111298","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393111298?lang=zh_cn&edition=full","pubTime":"2023-12-21 04:49","pubTimestamp":1703105350,"startTime":"0","endTime":"0","summary":"北京时间2023年12月21日04时49分，Maxcyte Inc股票出现波动，股价急速下挫5.02%。截至发稿，该股报4.71美元/股，成交量102.856万股，换手率0.99%，振幅5.65%。Maxcyte Inc股票所在的医疗器械行业中，整体跌幅为1.31%。其相关个股中，Vicarious Surgical Inc、Biosig Technologies Inc、Prosomnus Inc C/Wts 20/04/2028 涨幅较大，Vivos Therapeutics Inc、Intelligent Bio Solutions Inc、Sintx Technologies Inc较为活跃，换手率分别为49.85%、46.57%、45.83%，振幅较大的相关个股有Vicarious Surgical Inc、Prosomnus Inc C/Wts 20/04/2028 、Bone Biologics Corp C/Wts 13/10/2026 ，振幅分别为53.13%、51.38%、44.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312210449107a34a80b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312210449107a34a80b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392090758","title":"Maxcyte Inc盘中异动 股价大涨5.05%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392090758","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392090758?lang=zh_cn&edition=full","pubTime":"2023-12-19 23:34","pubTimestamp":1703000094,"startTime":"0","endTime":"0","summary":"北京时间2023年12月19日23时34分，Maxcyte Inc股票出现异动，股价快速上涨5.05%。截至发稿，该股报4.78美元/股，成交量24.7901万股，换手率0.24%，振幅4.40%。Maxcyte Inc股票所在的医疗器械行业中，整体涨幅为0.62%。其相关个股中，Prosomnus Inc C/Wts 20/04/2028 、Prosomnus Inc、Intelligent Bio Solutions Inc涨幅较大，Intelligent Bio Solutions Inc、Prosomnus Inc、Motus Gi Holdings Inc较为活跃，换手率分别为625.25%、229.60%、71.90%，振幅较大的相关个股有Prosomnus Inc C/Wts 20/04/2028 、Prosomnus Inc、Intelligent Bio Solutions Inc，振幅分别为124.00%、77.98%、49.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312192334557a346c15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312192334557a346c15&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.maxcyte.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.1852},{"period":"3month","weight":-0.0488},{"period":"6month","weight":-0.1004},{"period":"1year","weight":0.0821},{"period":"ytd","weight":-0.0468}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MaxCyte, Inc.于1998年7月31日根据特拉华州的法律和规定成立。他们是一家领先的商业细胞工程公司，专注于提供支持平台技术，以推进基于细胞的创新研究以及下一代细胞治疗的发现、开发和商业化。在过去的二十年里，他们开发了他们专有的Flow Electroporation平台并将其商业化，该平台促进了各种细胞的复杂工程。","exchange":"NASDAQ","name":"MaxCyte Inc","nameEN":"MaxCyte Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MaxCyte Inc,MXCT,MaxCyte Inc股票,MaxCyte Inc股票老虎,MaxCyte Inc股票老虎国际,MaxCyte Inc行情,MaxCyte Inc股票行情,MaxCyte Inc股价,MaxCyte Inc股市,MaxCyte Inc股票价格,MaxCyte Inc股票交易,MaxCyte Inc股票购买,MaxCyte Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MaxCyte Inc(MXCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MaxCyte Inc(MXCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}